Revolutionizing Recovery: Harnessing Mesenchymal Stem Cells for Spinal Cord Injury Repair
Welcome to an exploration of one of the most promising frontiers in medical science: the use of mesenchymal stem cells (MSCs) in the repair of spinal cord injuries. Spinal cord injuries can be devastating, altering lives in an instant and leaving individuals with significant physical challenges. Traditional therapies have made strides in improving outcomes, yet […]
Understanding Stem Cell Therapy for Back Treatment: A Personal Journey
In recent times, stem cell therapy has emerged as a promising solution for various health issues, notably back pain. Given the prevalence of back pain, it’s no surprise that this topic garners significant attention. This video offers an insightful look into stem cell therapy for back treatment, detailing the process, costs, and expected outcomes. Video […]
Stem Cell Miracles: Real Stories, Astonishing Outcomes
In recent times, the medical world has been abuzz with discussions about stem cell therapy and its potential to revolutionize treatments for various ailments. A recent segment on 17 News delved deep into this topic, shedding light on the miraculous improvements experienced by patients who have undergone this treatment. The Story of Mark Lewis Mark […]
Boost Stem Cell Outcomes with 5 Simple Techniques
Stem cell therapy is an innovative and promising approach to treat various conditions, especially those related to the lower back. However, to maximize the benefits of this treatment, certain techniques and practices can be adopted. Here are some key insights from Dr. Yoni Whitten’s video: 🏋️ Creating a comprehensive rehab routine can help ensure the […]
BioRestorative Therapies Activates Northwell Health for Phase 2 Clinical Trial on Chronic Lumbar Disc Disease
BioRestorative Therapies, Inc., a clinical-stage company specializing in stem cell-based therapies, has announced the activation of Northwell Health, the largest healthcare provider in New York State, for its ongoing Phase 2 clinical trial targeting chronic lumbar disc disease (cLDD). This activation permits patients in New York to participate in the BRTX-100 trial. The collaboration between […]
Neuroplast Completes Phase II Clinical Trial Inclusion for Traumatic Spinal Cord Injury
Neuroplast, a Dutch clinical-stage biotech company, has successfully concluded the patient inclusion for its Phase II clinical trial, focusing on Traumatic Spinal Cord Injury (TSCI). Here are the key details: Thought-Provoking Questions/Insights: Original Press Release
Say Goodbye to Pain: 5 Amazing Benefits of Stem Cell Therapy
In recent years, stem cell therapy has emerged as a groundbreaking treatment option for various chronic conditions and injuries. This innovative approach utilizes the body’s natural healing abilities to help alleviate pain, promote recovery, and improve overall health. In this article, we’ll explore the science behind stem cell therapy and discuss five amazing benefits that […]
A New Era in Pain Management: CELL Technologies Pursues Groundbreaking Stem Cell Therapy Approval
CELL Technologies Inc. has submitted clinical data from its stem cell program for pain management to Health Canada for approval. This follows a regulatory meeting on March 31st, 2023, and if approved, CELL would become the first regulatory-approved stem cell provider in North America. The data submitted covers three studies in arthritis, degenerative disc disease, […]
Jeff Gross, MD | Stem Cells, Regenerative Medicine & Longevity
In this episode of the Rest and Recovered podcast, Dr. Jeffrey Gross, a board-certified and fellowship-trained neurosurgeon, discusses his background and the evolution of his practice. With a degree in Biochemistry, Dr. Gross has a strong interest in cellular function and molecular biology. After over 20 years of practicing neurosurgery, particularly spinal neurosurgery, Dr. Gross […]
Creative Medical Technology Holdings Develops AlloStem™ Clinical Cell Line
PHOENIX, Oct. 20, 2022 /PRNewswire/ — Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ), a biotechnology company focused on a regenerative approach to immunotherapy, endocrinology, urology, neurology, and orthopedics, announced today that through predominantly internal and collaborative development, it has produced an allogenic Cell Line called AlloStem™, which includes a Master Cell Bank and a Drug Master File which shall […]